Switch to
More onapp

How to use scorecard? Learn more

Sun Pharma Advanced Research Co Ltd

SPARC
Health CarePharmaceuticals
SmallcapWith a market cap of ₹11,712 cr, stock is ranked 435
High RiskStock is 4.62x as volatile as Nifty
348.4512.30 (-3.41%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Low

Profitability and efficiency haven't been upto the mark

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹11,712 cr, stock is ranked 435
High RiskStock is 4.62x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
PB RatioPB Ratio
22.84
Dividend YieldDiv. Yield
Sector PESector PE
52.47
Sector PBSector PB
6.01
Sector Div YldSctr Div Yld
0.60%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy).

Financial TrendFinancial statements 

202020212022202386.57258.37144.09249.66-312.41-151.14-203.40-222.57
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Investor Presentation 
Announced OnJan 7, 2024

Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation | Download

Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation | Download

Investor Presentation 
Announced OnJan 6, 2024

Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation | Download

Sun Pharma Advanced Research Company Limited has informed the Exchange about Investor Presentation | Download

Press Release 
Announced OnJan 4, 2024

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated January 04, 2024, titled "SPARC to Present at the 42nd Annual J.P. Morgan Healthcare Conference". | Download

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated January 04, 2024, titled "SPARC to Present at the 42nd Annual J.P. Morgan Healthcare Conference". | Download

See all events